Skip to main content
Home
Menu
Main menu
  • About us
  • Entrepreneurs
  • Advisers
  • Investors
  • Portfolio
  • Jobs
  • News
  • Client login
  • Client login
  • UK
  • US

Portfolio

All
Current portfolio
Notable exits
TriVirum

Our numbers1

35
Active operating partners

Our awards

EIS Impact Award 2022 - Winner
Par Equity was recognised for its highly impactful investment and eventual realisation of Current Health, which was sold in October 2021 for $400m, making it Europe's second largest digital health exit ever.

Our accreditations and partnerships

Diversity VC Level 1
Tech She Can sponsor
Tech Talent Charter
Carbon Neutral (Carbon Neutral Britain)
Investing in Women Code
ESG_VC
BVCA
Linc Scotland
EISA
UKBAA
BBI
Par Equity LLP
3A Dublin Meuse
Edinburgh, EH3 6NW

Contact us

info@parequity.com

+44 (0)131 556 0044

  • UK
  • US

This is the Par Equity UK website

Find us
  • Terms of Use and Disclaimers
  • Privacy Policy
  • Cyber Essentials Plus Certified
  • Cookies

© 2022 Par Equity. Par Fund Management Limited (FRN 485668) is authorised and regulated by the Financial Conduct Authority.

1 As at 30th June 2022. Past performance should not be seen as an indication of future performance and any references to past or forecasted performance should not be relied upon as a guarantee of future returns.